Growth Metrics

Pacific Biosciences Of California (PACB) Income from Continuing Operations (2010 - 2026)

Pacific Biosciences Of California's quarterly Income from Continuing Operations came in at 8275000.0 in Q1 2026, up 98.06% year-on-year from 4178072.14 in Q1 2025, and up 79.5% quarter-over-quarter from 40371000.0 in Q4 2025.

Pacific Biosciences Of California has reported Income from Continuing Operations for 17 years, with the latest figure at 8275000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations rose 98.06% year-over-year to 8275000.0; the trailing twelve-month figure through Mar 2026 stood at 128576000.0 (up 80.45% YoY), and the FY2025 full-year result was 546376000.0, down 76.34% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 8275000.0, up from 40371000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 2371000.0 in Q4 2024, with the low at 426075000.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 87381470.59, with a median of 71394000.0 recorded in 2022.
  • Year-over-year, Income from Continuing Operations soared 102.89% in 2024 and tumbled 1802.7% in 2025.
  • Tracing PACB's Income from Continuing Operations over 5 years: stood at 84384000.0 in 2022, then climbed by 2.8% to 82018000.0 in 2023, then soared by 102.89% to 2371000.0 in 2024, then plunged by 1802.7% to 40371000.0 in 2025, then soared by 79.5% to 8275000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 8275000.0 (Q1 2026), 40371000.0 (Q4 2025), and 38000000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn -8.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -8.28 Mn
Dec 31, 2025 -40.37 Mn
Sep 30, 2025 -38.00 Mn
Jun 30, 2025 -41.93 Mn
Mar 31, 2025 -426.08 Mn
Dec 31, 2024 2.37 Mn
Sep 30, 2024 -60.73 Mn
Jun 30, 2024 -173.32 Mn
Mar 31, 2024 -78.18 Mn
Dec 31, 2023 -82.02 Mn
Sep 30, 2023 -66.87 Mn
Jun 30, 2023 -69.83 Mn
Mar 31, 2023 -88.02 Mn
Dec 31, 2022 -84.38 Mn
Sep 30, 2022 -76.97 Mn
Jun 30, 2022 -71.39 Mn
Mar 31, 2022 -81.50 Mn
Dec 31, 2021 -69.33 Mn
Jun 30, 2021 -41.16 Mn
Mar 31, 2021 -35.50 Mn
Dec 31, 2020 74.94 Mn
Sep 30, 2020 -23.71 Mn
Jun 30, 2020 -23.52 Mn
Mar 31, 2020 -32.98 Mn
Dec 31, 2019 -18.60 Mn
Sep 30, 2019 -28.78 Mn
Jun 30, 2019 -25.02 Mn
Mar 31, 2019 -30.76 Mn
Dec 31, 2018 -31.25 Mn
Sep 30, 2018 -25.29 Mn
Jun 30, 2018 -22.34 Mn
Mar 31, 2018 -24.53 Mn
Dec 31, 2017 -21.15 Mn
Sep 30, 2017 -22.20 Mn
Jun 30, 2017 -25.21 Mn
Mar 31, 2017 -24.14 Mn
Dec 31, 2016 -18.71 Mn
Sep 30, 2016 -17.56 Mn
Jun 30, 2016 -18.87 Mn
Mar 31, 2016 -19.34 Mn
Dec 31, 2015 -1.84 Mn
Sep 30, 2015 1.87 Mn
Jun 30, 2015 -12.07 Mn
Mar 31, 2015 -20.03 Mn
Dec 31, 2014 -18.62 Mn
Sep 30, 2014 -9.13 Mn
Jun 30, 2014 -19.00 Mn
Mar 31, 2014 -18.93 Mn
Dec 31, 2013 -17.70 Mn
Sep 30, 2013 -20.62 Mn
Jun 30, 2013 -20.67 Mn
Mar 31, 2013 -21.03 Mn
Dec 31, 2012 -21.76 Mn
Sep 30, 2012 -22.65 Mn
Jun 30, 2012 -22.62 Mn
Mar 31, 2012 -27.51 Mn
Dec 31, 2011 -22.69 Mn
Sep 30, 2011 -29.44 Mn
Jun 30, 2011 -22.66 Mn
Mar 31, 2011 -34.97 Mn
Dec 31, 2010 -36.59 Mn
Sep 30, 2010 -40.70 Mn
Jun 30, 2010 -32.68 Mn